Patients preferences in treatment for neovascular age-related macular degeneration in clinical routine

British Journal of Ophthalmology, 05/14/2012

Time trade–off (TTO) performed best in this sample of elderly neovascular age–related macular degeneration (nvAMD) patients undergoing anti–VEGF therapy. Better or worse eye treatment was not associated with a change in reported utilities or visual functioning in patients with newly diagnosed nvAMD. Directly elicited, vision–specific utilities gained with TTO seem to be sensitive to a change in vision status.

Print Article Summary Cat 2 CME Report